Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Finasteride side effects in young men may be linked to specific gene variations.

Sebaceous glands in male pattern hair loss patients have more lobules and might cause early hair growth phase shifts.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

A small percentage of minoxidil users may develop an allergic skin reaction.

5α-reductases increase epitestosterone's effect on androgen receptors.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

Men with early-onset hair loss have more heart disease risk factors.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Androgens improve memory in adolescent male rats by acting on brain receptors.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Found microRNA differences in hair cells, suggesting potential treatment targets for hair loss.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.